These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3429165)

  • 1. The use of oxybutynin in urological practice.
    Kirkali Z; Whitaker RH
    Int Urol Nephrol; 1987; 19(4):385-91. PubMed ID: 3429165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
    Moore KH; Hay DM; Imrie AE; Watson A; Goldstein M
    Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
    J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bladder dysfunction in children].
    Bensman A; Deschenes G; Audry G; Grapin C
    Ann Urol (Paris); 1995; 29(5):302-5. PubMed ID: 8638913
    [No Abstract]   [Full Text] [Related]  

  • 6. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
    Moisey CU; Stephenson TP; Brendler CB
    Br J Urol; 1980 Dec; 52(6):472-5. PubMed ID: 7006730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of unstable bladder with oxybutynin hydrochloride. Our clinical experience in 80 cases].
    Alladio F; Arena G; Ferrando U; Pigato M; Sesia G
    Minerva Urol Nefrol; 1987; 39(4):359-62. PubMed ID: 3451374
    [No Abstract]   [Full Text] [Related]  

  • 8. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
    Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
    Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticholinergic medication for the unstable bladder: prospective trials of imipramine/propantheline versus penthienate and oxybutynin versus penthienate.
    Clarke B
    Int Urogynecol J Pelvic Floor Dysfunct; 1996; 7(4):191-5. PubMed ID: 10895803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxybutynin: is it safe?
    Baigrie RJ; Kelleher JP; Fawcett DP; Pengelly AW
    Br J Urol; 1988 Oct; 62(4):319-22. PubMed ID: 3191355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ; Cardozo LD; Versi E; Cooper D
    Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence].
    De Castro R; Casolari E; Ricci S
    Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo.
    Thüroff JW; Bunke B; Ebner A; Faber P; de Geeter P; Hannappel J; Heidler H; Madersbacher H; Melchior H; Schäfer W
    J Urol; 1991 Apr; 145(4):813-6; discussion 816-7. PubMed ID: 2005707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxybutynin chloride on bladder spasm following transurethral surgery.
    Wein AJ; Hanno PM; Raezer DM; Benson GS
    Urology; 1978 Aug; 12(2):184-6. PubMed ID: 358527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of propiverine, atropine and oxybutynin on bladder instability in rats with infravesical outlet obstruction.
    Kwak TI; Lee JG
    Br J Urol; 1998 Aug; 82(2):272-7. PubMed ID: 9722766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.
    Kasabian NG; Bauer SB; Dyro FM; Colodny AH; Mandell J; Retik AB
    Am J Dis Child; 1992 Jul; 146(7):840-3. PubMed ID: 1496955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.